- Home
- LESL vs ASRT Comparison
LESL vs ASRT Comparison
Compare LESL & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LESL
- ASRT
- Stock Information
- Founded
- LESL 1963
- ASRT 1995
- Country
- LESL United States
- ASRT United States
- Employees
- LESL N/A
- ASRT N/A
- Industry
- LESL Diversified Commercial Services
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- LESL Miscellaneous
- ASRT Health Care
- Exchange
- LESL Nasdaq
- ASRT Nasdaq
- Market Cap
- LESL 66.9M
- ASRT 79.1M
- IPO Year
- LESL 2020
- ASRT 1997
- Fundamental
- Price
- LESL $4.75
- ASRT $0.88
- Analyst Decision
- LESL Hold
- ASRT Strong Buy
- Analyst Count
- LESL 9
- ASRT 1
- Target Price
- LESL $33.25
- ASRT $3.00
- AVG Volume (30 Days)
- LESL 193.8K
- ASRT 323.8K
- Earning Date
- LESL 11-24-2025
- ASRT 11-10-2025
- Dividend Yield
- LESL N/A
- ASRT N/A
- EPS Growth
- LESL N/A
- ASRT N/A
- EPS
- LESL N/A
- ASRT N/A
- Revenue
- LESL $1,250,568,000.00
- ASRT $117,099,000.00
- Revenue This Year
- LESL N/A
- ASRT N/A
- Revenue Next Year
- LESL $0.64
- ASRT $6.75
- P/E Ratio
- LESL N/A
- ASRT N/A
- Revenue Growth
- LESL N/A
- ASRT N/A
- 52 Week Low
- LESL $4.31
- ASRT $0.51
- 52 Week High
- LESL $72.60
- ASRT $1.16
- Technical
- Relative Strength Index (RSI)
- LESL 68.45
- ASRT 51.53
- Support Level
- LESL $5.43
- ASRT $0.87
- Resistance Level
- LESL $6.92
- ASRT $0.93
- Average True Range (ATR)
- LESL 0.44
- ASRT 0.04
- MACD
- LESL 0.37
- ASRT -0.01
- Stochastic Oscillator
- LESL 67.52
- ASRT 7.03
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.